Bladder Cancer Incidence and Mortality by Year, White Individuals, New York State Excl New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 1,907 21.6 20.6-22.6 1,406 39.3 37.2-41.6 501 9.7 8.9-10.6 585 7.0 6.5-7.6 424 13.3 12.0-14.7 161 3.2 2.8-3.8
1977 1,970 22.0 21.0-23.0 1,446 39.4 37.3-41.6 524 10.2 9.4-11.1 583 6.9 6.4-7.5 410 12.7 11.4-14.0 173 3.4 2.9-4.0
1978 2,070 22.9 21.9-24.0 1,504 41.1 38.9-43.3 566 10.9 10.1-11.9 595 6.9 6.4-7.5 419 12.9 11.6-14.3 176 3.4 2.9-3.9
1979 2,091 22.7 21.8-23.8 1,579 42.6 40.5-44.9 512 9.5 8.7-10.4 579 6.7 6.2-7.3 389 11.7 10.5-13.0 190 3.6 3.1-4.2
1980 2,201 23.6 22.6-24.6 1,622 42.9 40.7-45.1 579 10.7 9.8-11.6 555 6.2 5.7-6.7 392 11.6 10.4-12.9 163 3.0 2.6-3.5
1981 2,155 22.8 21.8-23.8 1,603 42.0 39.9-44.3 552 10.1 9.3-11.0 615 6.8 6.3-7.4 436 13.0 11.7-14.3 179 3.3 2.8-3.8
1982 2,326 24.4 23.4-25.4 1,701 43.9 41.8-46.2 625 11.3 10.4-12.2 564 6.2 5.7-6.7 397 11.5 10.3-12.7 167 3.0 2.5-3.5
1983 2,246 23.3 22.3-24.3 1,678 43.4 41.2-45.6 568 10.1 9.3-11.0 560 6.0 5.6-6.6 409 12.1 10.9-13.4 151 2.6 2.2-3.1
1984 2,261 23.2 22.3-24.2 1,636 41.6 39.5-43.7 625 11.1 10.2-12.0 570 6.2 5.7-6.7 389 11.6 10.4-12.9 181 3.1 2.7-3.6
1985 2,387 24.4 23.4-25.4 1,746 44.1 42.0-46.3 641 11.3 10.4-12.2 562 6.0 5.5-6.5 384 10.9 9.8-12.1 178 3.1 2.6-3.6
1986 2,472 24.9 24.0-26.0 1,821 45.1 42.9-47.3 651 11.4 10.5-12.3 574 6.1 5.6-6.6 403 11.9 10.7-13.2 171 2.9 2.5-3.4
1987 2,330 23.3 22.3-24.3 1,675 41.0 39.0-43.1 655 11.2 10.4-12.1 530 5.5 5.1-6.0 356 10.0 9.0-11.2 174 2.9 2.5-3.4
1988 2,341 23.4 22.4-24.4 1,704 41.8 39.8-44.0 637 10.9 10.1-11.8 558 5.7 5.2-6.2 374 10.1 9.1-11.3 184 3.0 2.6-3.5
1989 2,400 23.6 22.7-24.6 1,758 42.7 40.6-44.8 642 10.8 10.0-11.7 541 5.5 5.0-5.9 388 10.7 9.6-11.8 153 2.5 2.1-2.9
1990 2,502 24.5 23.6-25.5 1,794 43.1 41.0-45.2 708 12.0 11.1-12.9 550 5.5 5.1-6.0 361 9.9 8.8-11.0 189 3.0 2.6-3.5
1991 2,437 23.5 22.6-24.5 1,769 41.8 39.8-43.8 668 11.1 10.3-12.0 539 5.3 4.8-5.8 377 10.0 9.0-11.1 162 2.6 2.2-3.0
1992 2,457 23.6 22.7-24.6 1,771 41.8 39.8-43.8 686 11.4 10.6-12.3 566 5.5 5.0-5.9 338 8.9 7.9-9.9 228 3.6 3.1-4.1
1993 2,611 24.8 23.8-25.7 1,837 42.4 40.4-44.4 774 12.6 11.7-13.6 557 5.3 4.9-5.8 374 9.8 8.8-10.9 183 2.8 2.4-3.2
1994 2,485 23.6 22.6-24.5 1,791 41.2 39.3-43.2 694 11.4 10.5-12.3 572 5.4 5.0-5.9 383 9.7 8.7-10.8 189 2.8 2.5-3.3
1995 2,653 25.0 24.0-26.0 1,867 42.6 40.6-44.6 786 12.8 11.9-13.7 547 5.1 4.7-5.6 363 8.9 8.0-9.9 184 2.8 2.4-3.2
1996 2,865 26.8 25.8-27.8 2,108 47.7 45.7-49.9 757 12.3 11.4-13.2 601 5.6 5.1-6.0 401 10.0 9.0-11.0 200 3.0 2.6-3.5
1997 2,990 27.8 26.8-28.8 2,148 48.0 46.0-50.1 842 13.5 12.6-14.4 624 5.7 5.3-6.2 418 10.0 9.1-11.0 206 3.1 2.7-3.5
1998 3,093 28.5 27.5-29.5 2,264 49.9 47.8-52.0 829 13.4 12.5-14.4 579 5.2 4.8-5.7 409 9.9 8.9-10.9 170 2.5 2.1-2.9
1999 3,129 28.6 27.6-29.6 2,268 49.4 47.4-51.5 861 13.7 12.8-14.6 590 5.3 4.8-5.7 407 9.6 8.7-10.6 183 2.6 2.3-3.1
2000 3,141 28.3 27.4-29.3 2,271 49.0 46.9-51.0 870 13.5 12.6-14.5 601 5.3 4.9-5.7 415 9.4 8.5-10.4 186 2.7 2.3-3.1
2001 3,146 28.1 27.2-29.1 2,310 49.5 47.4-51.5 836 13.0 12.1-14.0 613 5.3 4.9-5.8 432 9.9 9.0-10.9 181 2.5 2.2-2.9
2002 3,314 29.4 28.4-30.4 2,474 52.1 50.0-54.2 840 13.0 12.2-14.0 609 5.3 4.9-5.7 407 9.1 8.2-10.1 202 2.9 2.5-3.4
2003 3,368 29.6 28.6-30.6 2,493 51.5 49.5-53.6 875 13.5 12.6-14.4 563 4.8 4.4-5.2 381 8.4 7.6-9.3 182 2.5 2.2-3.0
2004 3,477 30.3 29.3-31.4 2,578 53.1 51.0-55.2 899 13.8 12.9-14.8 605 5.1 4.7-5.6 419 9.0 8.1-9.9 186 2.6 2.2-3.0
2005 3,526 30.5 29.5-31.5 2,602 52.9 50.9-55.0 924 14.0 13.1-14.9 565 4.7 4.3-5.1 383 8.1 7.3-9.0 182 2.5 2.1-2.9
2006 3,449 29.5 28.5-30.5 2,554 51.4 49.4-53.4 895 13.6 12.7-14.5 576 4.8 4.4-5.2 394 8.3 7.5-9.1 182 2.5 2.2-2.9
2007 3,437 29.2 28.2-30.2 2,539 50.1 48.1-52.1 898 13.6 12.7-14.6 640 5.2 4.8-5.7 458 9.4 8.5-10.3 182 2.5 2.1-2.9
2008 3,566 29.7 28.8-30.7 2,688 52.3 50.4-54.4 878 12.9 12.1-13.8 649 5.2 4.8-5.6 446 9.0 8.2-9.9 203 2.7 2.3-3.1
2009 3,613 29.8 28.8-30.8 2,713 51.9 49.9-53.9 900 13.1 12.2-14.0 641 5.1 4.7-5.5 485 9.7 8.8-10.6 156 2.0 1.7-2.4
2010 3,375 27.5 26.5-28.4 2,552 48.1 46.2-50.0 823 11.9 11.1-12.8 666 5.2 4.8-5.6 467 9.0 8.2-9.9 199 2.6 2.2-3.0
2011 3,650 29.6 28.6-30.6 2,726 50.6 48.7-52.6 924 13.5 12.6-14.4 617 4.7 4.3-5.1 437 8.4 7.6-9.2 180 2.3 2.0-2.7
2012 3,751 29.7 28.8-30.7 2,782 51.0 49.1-53.0 969 13.6 12.8-14.6 641 4.9 4.5-5.3 443 8.3 7.6-9.1 198 2.5 2.2-2.9
2013 3,788 29.9 28.9-30.9 2,832 51.5 49.6-53.5 956 13.5 12.6-14.4 643 4.9 4.5-5.3 465 8.6 7.9-9.5 178 2.3 1.9-2.6
2014 3,703 28.6 27.6-29.5 2,772 49.0 47.2-50.9 931 12.8 11.9-13.6 680 5.0 4.7-5.5 461 8.4 7.6-9.2 219 2.8 2.5-3.3
2015 3,590 27.5 26.6-28.4 2,679 46.6 44.8-48.5 911 12.7 11.9-13.6 633 4.6 4.3-5.0 438 7.8 7.1-8.6 195 2.5 2.2-2.9
2016 3,748 28.3 27.3-29.2 2,822 48.2 46.4-50.1 926 12.6 11.7-13.4 664 4.9 4.5-5.3 476 8.5 7.7-9.3 188 2.3 2.0-2.7
2017 3,674 27.4 26.5-28.3 2,765 46.8 45.0-48.6 909 12.1 11.3-13.0 645 4.6 4.2-5.0 445 7.7 7.0-8.5 200 2.4 2.1-2.8
2018 3,651 26.7 25.8-27.6 2,741 45.3 43.6-47.1 910 12.0 11.2-12.9 647 4.6 4.2-4.9 464 7.9 7.2-8.6 183 2.3 1.9-2.7
2019 3,652 26.4 25.5-27.3 2,748 44.7 43.0-46.4 904 11.9 11.1-12.7 592 4.1 3.8-4.5 432 7.3 6.6-8.0 160 1.9 1.6-2.3
2020 3,343 23.8 23.0-24.6 2,538 40.6 39.0-42.2 805 10.4 9.7-11.2 612 4.2 3.9-4.6 449 7.6 6.9-8.3 163 2.0 1.7-2.3

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.